MENU
CLOSE
Home
News
2016 Announcements
2016 Announcements
Filters:
Category
Latest
2016 Announcements
2017 Announcements
2018 Announcements
2019 Announcements
2020 Announcements
2021 Announcements
2022 Announcements
2023 Announcements
2024 Announcements
Clinical
Corporate
Financial
News
Newsletter
Pages
Presentation
Recruitment
Regulatory
Stories
Appendix 4C – Quarterly report
2016 Announcements
31.01.2017
Appendix 3Y
2016 Announcements
22.12.2016
CLINUVEL Newsletter – December 2016
2016 Announcements
20.12.2016
Appendix 3Y
2016 Announcements
12.12.2016
Results of Meeting
2016 Announcements
28.11.2016
Chair’s Address to the Annual General Meeting
2016 Announcements
27.11.2016
Managing Director’s AGM Presentation
2016 Announcements
27.11.2016
CLINUVEL agrees with FDA on New Drug Application timelines
2016 Announcements
08.11.2016
Response to Price Query
2016 Announcements
31.10.2016
Appendix 4C
2016 Announcements
31.10.2016
Notice of Annual General Meeting/Proxy Form
2016 Announcements
26.10.2016
Appendix 4G
2016 Announcements
26.10.2016
CLINUVEL relocates Melbourne office
2016 Announcements
22.10.2016
.
1
2
3
4
›
About
About CLINUVEL
People
Corporate Governance
Photomedicine Foundation
Annual Reports
Pharmaceuticals
About Pharmaceuticals
The Science
Disease Entities
Products
PhotoCosmetics
About PhotoCosmetics
Polychromatic Photoprotection
DNA Repair
Melanogenesis
Investors
Investors Information
ASX Announcements
Analyst Coverage
Media Coverage
Company Snapshot
Financial Summary
Shareholder Information
Investor Enquiry
News
Contact
Store
Go To Top